Yaming Zhou

Prof. Dr. Yaming Zhou

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
XSXiyu Song
Xiyu Song
YWYao Wang
Yao Wang
CWChen Wang
Chen Wang
XGXiangyu Gao
Xiangyu Gao
YZYaming Zhou
Yaming Zhou
Peng LiPeng Li
Peng Li

25 December 2022 in Advanced Science
Verified
Journal Article
Open access
JLJianing Li
Jianing Li
WLWanyue Lu
Wanyue Lu
YYYannan Yang
Yannan Yang
RXRuiqing Xiang
Ruiqing Xiang
YLYun Ling
Yun Ling
YZYaming Zhou
Yaming Zhou
Nano‐immunotherapy has been recognized as a highly promising strategy for cancer treatment in recent decades, which combines nanotechnology and immunotherapy to combat against tumors. Hybrid nanomaterials consisting of at least two constituents with distinct compositions and properties, usually organic and inorganic, have been engineered with integrated functions and enormous potential in boosting cancer immunotherapy. This review provides a summary of hybrid nanomaterials reported for cancer immunotherapy, including nanoscale metal–organic frameworks, metal–phenolic networks, mesoporous organosilica nanoparticles, metallofullerene nanomaterials, polymer–lipid, and biomacromolecule‐based hybrid nanomaterials. The combination of immunotherapy with chemotherapy, chemodynamic therapy, radiotherapy, radiodynamic therapy, photothermal therapy, photodynamic therapy, and sonodynamic therapy based on hybrid nanomaterials is also discussed. Finally, the current challenges and the prospects for designing hybrid nanomaterials and their application in cancer immunotherapy are outlined.

5 September 2013 in Inorganic Chemistry
Verified
Journal Article
Closed access
QZQingshu Zheng
Qingshu Zheng
FYFeilong Yang
Feilong Yang
MDMingli Deng
Mingli Deng
YLYun Ling
Yun Ling
XLXiaofeng Liu
Xiaofeng Liu
YZYaming Zhou
Yaming Zhou

24 March 2017 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JLJie Li
Jie Li
JWJiaxi Wang
Jiaxi Wang
YLYun Ling
Yun Ling
ZCZhenxia Chen
Zhenxia Chen
MGMingxia Gao
Mingxia Gao
YZYaming Zhou
Yaming Zhou
The synthesized Fe3O4@Mg-MOF-74 core–shell nanoparticles show effective and selective enrichment of 441 N-glycosylation sites of 418 glycopeptides from 125 glycoproteins in 1 μL of human serum.

6 November 2012 in CrystEngComm
Verified
Journal Article
Closed access
PDF file
FZFupeng Zhai
Fupeng Zhai
QZQingshu Zheng
Qingshu Zheng
ZCZhenxia CHEN
Zhenxia CHEN
YLYun Ling
Yun Ling
XLXiaofeng Liu
Xiaofeng Liu
YZYaming Zhou
Yaming Zhou
A 2D phosphonate MOF {[Ni(Hptz)2]·7H2O}n (H2ptz = 4-(1,2,4-triazol-4-yl)phenylphosphonic acid) (2) is obtained through crystal transformation from a trinuclear compound [Ni3(Hptz)6·(H2O)6]·9H2O (1). Studies of chemical stability show that 2 retains its crystallinity in boiling water and organic solvents. 2 also exhibits high adsorption capacity for CO2 (80 cm3(STP) g−1) and selective separation of CO2 over N2.

31 May 2011 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
YLYun Ling
Yun Ling
ZCZhenxia CHEN
Zhenxia CHEN
FZFu-Peng Zhai
Fu-Peng Zhai
YZYaming Zhou
Yaming Zhou
LWLin-Hong Weng
Lin-Hong Weng
DZDong-Yuan Zhao
Dong-Yuan Zhao
A three-dimensional (3D) metal–organic framework {[Zn2(HBDC)2(dmtrz)2]·guest}n with pcu net has been solvothermally synthesized, which shows selective adsorption of linear and monobranched hexane isomers over a dibranched one.